Shopping Cart
Remove All
Your shopping cart is currently empty
EFdA-TP tetrasodium, a potent nucleoside reverse transcriptase (RT) inhibitor, effectively halts RT-catalyzed DNA synthesis by acting as an immediate or delayed chain terminator (ICT or DCT). It employs multiple mechanisms to inhibit HIV-1 RT [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,270 | 10-14 weeks | 10-14 weeks | |
| 50 mg | $2,980 | 10-14 weeks | 10-14 weeks | |
| 100 mg | $4,000 | 10-14 weeks | 10-14 weeks |
| Description | EFdA-TP tetrasodium, a potent nucleoside reverse transcriptase (RT) inhibitor, effectively halts RT-catalyzed DNA synthesis by acting as an immediate or delayed chain terminator (ICT or DCT). It employs multiple mechanisms to inhibit HIV-1 RT [1]. |
| In vitro | EFdA-TP tetrasodium, at concentrations ranging from 0.05-10 μM and applied for 15 minutes, acts as a translocation-defective reverse transcriptase (RT) inhibitor, significantly hindering RT-catalyzed DNA synthesis. It operates both as an immediate chain terminator (ICT) and as a delayed chain terminator (DCT), allowing for the insertion of one more deoxynucleotide triphosphate (dNTP) before effectively halting DNA synthesis [1]. |
| Molecular Weight | 621.12 |
| Formula | C12H11FN5Na4O12P3 |
| Cas No. | 2883783-00-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.